ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,589Medicare Part D Prescriptions Filled, Including Refills

Rank: 195 out of 1000

$710K Total Retail Price of All Prescriptions

Rank: 139 out of 1000

569 Patients Receiving at Least One Drug in Part D
49%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 569 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

31% of this provider’s 569 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 8,017 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 616 355 S3 1 1
SIMVASTATIN 519 353 2 3
LISINOPRIL 506 327 3 5
FUROSEMIDE 430 311 4 7
OMEPRAZOLE 419 299 5 2
METOPROLOL TARTRATE 330 242 6 19
HYDRALAZINE HCL 247 205 7 74
LEVOTHYROXINE SODIUM 247 158 7 4
TRAMADOL HCL 237 128 9 13
CITALOPRAM HBR 233 153 10 17
RISPERIDONE 211 152 11 87
EXELON 200 167 12 108
GABAPENTIN 193 109 13 11
AMLODIPINE BESYLATE 174 110 14 6
ISOSORBIDE MONONITRATE ER 168 121 15 71
METFORMIN HCL 161 104 16 8
CLOPIDOGREL 147 87 17 35
POTASSIUM CHLORIDE 146 89 18 10
TRAZODONE HCL 141 75 19 29
CARVEDILOL 136 88 20 15
CLONIDINE HCL 135 91 21 27
PREDNISONE 129 90 22 42
PANTOPRAZOLE SODIUM 126 66 23 28
IBUPROFEN 125 82 24 94
DONEPEZIL HCL 124 106 25 32
KLOR-CON M20 123 100 26 66
LEVEMIR 115 86 27 179
CYCLOBENZAPRINE HCL 109 61 R 28 39
QUETIAPINE FUMARATE 107 57 29 75
LANTUS 105 62 30 68
SERTRALINE HCL 104 68 31 26
PLAVIX 102 64 32 49
RANITIDINE HCL 97 50 33 37
ALLOPURINOL 97 81 33 31
WARFARIN SODIUM 96 62 35 22
ZOLPIDEM TARTRATE 89 63 36 16
PROMETHAZINE HCL 85 44 R 37 54
HYDROCHLOROTHIAZIDE 84 43 38 9
ATENOLOL 83 56 39 24
PROAIR HFA 83 22 39 50
LOVASTATIN 81 60 41 41
NAMENDA 78 64 42 43
VENTOLIN HFA 73 34 43 83
KLOR-CON M10 70 52 44 216
BENZTROPINE MESYLATE 69 47 R 45 180
SULFAMETHOXAZOLE-TRIMETHOPRIM 69 33 45 70
AMIODARONE HCL 67 48 47 178
FAMOTIDINE 63 52 48 88
SEROQUEL 59 31 49 157
ATORVASTATIN CALCIUM 59 31 49 18
TAMSULOSIN HCL 59 44 49 33
NOVOLIN R 58 33 52 185
SPIRIVA 58 22 52 64
BACLOFEN 58 20 52 129
PHENYTOIN SODIUM EXTENDED 56 44 55 115
CIPROFLOXACIN HCL 55 34 56 46
SPIRONOLACTONE 55 40 56 78
LOSARTAN POTASSIUM 53 29 58 25
BENAZEPRIL HCL 53 42 58 61
BUSPIRONE HCL 51 20 60 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.